---
title: Classification and risk stratification in T-lineage acute lymphoblastic leukemia
date: '2024-10-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39357057/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241003195203&v=2.18.0.post9+e462414
source: Blood
description: Cure rates for patients with acute lymphoblastic leukemia (ALL) have
  improved markedly in recent decades, in part due to risk stratification incorporating
  leukemia genomics, response to treatment, and clinical features to be able to determine
  at diagnosis which patients are more likely to relapse or have refractory disease.
  While risk stratification is well-developed for patients with B lineage ALL (B-ALL),
  it remains challenging for those with T lineage ALL (T-ALL). Prognostic factors
  ...
disable_comments: true
---
Cure rates for patients with acute lymphoblastic leukemia (ALL) have improved markedly in recent decades, in part due to risk stratification incorporating leukemia genomics, response to treatment, and clinical features to be able to determine at diagnosis which patients are more likely to relapse or have refractory disease. While risk stratification is well-developed for patients with B lineage ALL (B-ALL), it remains challenging for those with T lineage ALL (T-ALL). Prognostic factors ...